In-Vivo Evaluation of Nebulized Aerosols Delivered Via Nasal Route

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
Interface Acceptance During Delivery of Aerosol Medicine to an Infant or Child
Interventions
BEHAVIORAL

inhaled normal saline using different interfaces.

A Hudson nebulizer will be loaded with 3 mls of normal saline and operated at 7 L/min of wall air for 3 minutes with each scenario with a 5-minute interval between interfaces. The infants will be videotape while they receive inhaled aerosol, and sound will be captured. The camera will be positioned so the face of the parent holding the child will not be visible.

Trial Locations (1)

72202

Arkansas Children's Hospital, Little Rock

All Listed Sponsors
lead

Arkansas Children's Hospital Research Institute

OTHER

NCT02082379 - In-Vivo Evaluation of Nebulized Aerosols Delivered Via Nasal Route | Biotech Hunter | Biotech Hunter